Locate Cheyenne buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.
|
Dr. Georgia Louise Young, D.O.
PO Box 1183
Cheyenne, WY 82003
Main Tel: (208) 304-5278
|
|
Dr. Julie B. Maggiolo, M.D.
Cheyenne Regional Medical Center
214 East 23rd Street
Cheyenne, WY 82001
Main Tel: (307) 633-7370
|
|
Dr. Eugene Leonard Roberts, Jr., M.D.
Cheyenne Regional Medical Center
214 East 23rd Street
Cheyenne, WY 82001
Main Tel: (704) 965-2002
|
|
Dr. Georgia Louise Young, D.O.
2909 Bent St.
Suite B2
Cheyenne, WY 82001
Main Tel: (307) 772-1836
|
|
Dr. James G. Haller, M.D.
123 Cole Shopping Center
Cheyenne, WY 82001
Main Tel: (307) 634-8802
|
|
Dr. Douglas W. Edgren, M.D.
1331 Prairie Avenue
Cheyenne, WY 82009
Main Tel: (307) 632-0728
|
|
Dr. Tharenie Sivarajah, M.D.
201 Walterscheid Boulevard
Apt 5-206
Cheyenne, WY 82007
Main Tel: (307) 274-5560
|
|
Jonathan Benaknin, D.O.
Behavioral Health Services
2600 East 18th Street
Cheyenne, WY 82001
Main Tel: (307) 634-2273
|
|
Jasper James Chen, M.D.
Cheyenne Regional Medical Center
2600 East 18th Street, Behavioral Health
Cheyenne, WY 82001
Main Tel: 603-650-5000
|
|
Dr. Lopa Bakul Zaveri, M.D.
Cheyenne Health and Wellness Center
2508 East Fox Farm Road
Cheyenne, WY 82007
Main Tel: (307) 635-3618
|
Buprenorphine Shown Safe and Effective in Reducing Opioid Use
A scholarly article published in The American Journal of Psychiatry found that buprenorphine was “noninferior” in elimiating opioid misuse as compared with methadone dosing. Noninferior is another way of saying reasonably similar in effectiveness. The study was based on 272 patients meeting diagnostic criteria for Opioid Use Disorder, and was conducted over a 24 week Read More
Opioid Use Disorder and Medication Assistance
Nearly every U.S. family is affected by addiction with opioid use disorder rising significantly in the last 10 years. Despite this trend, a surprising number of individuals still do not have access to medication-assisted therapy. Buprenorphine based medications enjoy a proven track record of success in helping patients achieve long lasting stablization and elimination of Read More
The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.